Pilot use of 3-dimensional photography to aid clinical decision-making in craniofacial morphea

Craniofacial morphea includes progressive hemifacial atrophy, also known as Parry-Romberg Syndrome, and frontoparietal linear morphea, or en coup de sabre. These conditions cause damage to skin, fat, muscle, cartilage, and in severe cases, bone.1 Disease onset often occurs between 5 and 15 years, with early involvement indicating a worse skeletal prognosis and disfigurement.2 Although the etiopathogenesis is not fully understood, craniofacial morphea is considered an inflammatory condition in which immunomodulatory medications can effectively halt progression.